109 related articles for article (PubMed ID: 9075066)
1. Effect of dibutyryl cyclic AMP on plasma renin activity in normal men and patients with primary aldosteronism.
Fukuda N; Soma M; Kubo A; Kunimoto M; Watanabe Y; Izumi Y; Kanmatsuse K
J Endocrinol Invest; 1997 Jan; 20(1):13-7. PubMed ID: 9075066
[TBL] [Abstract][Full Text] [Related]
2. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
3. Effects of metoclopramide, a dopamine antagonist, on secretion of aldosterone and renin release in patients with primary aldosteronism.
Mizuno K; Yamazaki M; Ikeda K; Yaginuma K; Hashimoto S; Fukuchi S
Jpn Heart J; 1983 Nov; 24(6):917-24. PubMed ID: 6323781
[TBL] [Abstract][Full Text] [Related]
4. Establishment of reference values for endocrine tests. III: Primary aldosteronism.
Baas SJ; Endert E; Fliers E; Prummel MF; Wiersinga WM
Neth J Med; 2003 Feb; 61(2):37-43. PubMed ID: 12735419
[TBL] [Abstract][Full Text] [Related]
5. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.
Balaş M; Zosin I; Maser-Gluth C; Hermsen D; Cupisti K; Schott M; Schinner S; Knoefel WT; Scherbaum WA; Willenberg HS
Hypertens Res; 2010 Aug; 33(8):850-6. PubMed ID: 20520614
[TBL] [Abstract][Full Text] [Related]
6. A specific role for saline or the sodium ion in the regulation of renin and aldosterone secretion.
Tuck ML; Dluhy RG; Williams GH
J Clin Invest; 1974 Apr; 53(4):988-95. PubMed ID: 4360859
[TBL] [Abstract][Full Text] [Related]
7. Variability in the renin/aldosterone profile under random and standardized sampling conditions in primary aldosteronism.
Tanabe A; Naruse M; Takagi S; Tsuchiya K; Imaki T; Takano K
J Clin Endocrinol Metab; 2003 Jun; 88(6):2489-94. PubMed ID: 12788844
[TBL] [Abstract][Full Text] [Related]
8. Tp-e interval, Tp-e/QT and Tp-e/QTc ratio in hypertensive patients with primary aldosteronism.
Demirtas D; Sumbul HE; Bulut A; Demirtas AO; Gulumsek E; Koca H; Icen YK; Koc M
Clin Exp Hypertens; 2020; 42(1):93-98. PubMed ID: 31204516
[No Abstract] [Full Text] [Related]
9. Evaluation of plasma aldosterone to plasma renin activity ratio in patients with primary aldosteronism.
Ignatowska-Switalska H; Chodakowska J; Januszewicz W; Feltynowski T; Adamczyk M; Lewandowski J
J Hum Hypertens; 1997 Jun; 11(6):373-8. PubMed ID: 9249232
[TBL] [Abstract][Full Text] [Related]
10. [The effect of trilostane, a new inhibitor of adrenal steroid biosynthesis, on blood pressure, plasma aldosterone and other steroid hormones, serum potassium and plasma renin activity in primary aldosteronism (author's transl)].
Shigetomi S; Fukuchi S; Haruyama K; Yamazaki M
Nihon Naibunpi Gakkai Zasshi; 1982 Mar; 58(3):184-98. PubMed ID: 6212269
[TBL] [Abstract][Full Text] [Related]
11. Aldosterone-to-renin ratio acts as the predictor distinguishing the primary aldosteronism from chronic kidney disease.
Chen WG; Zhou TT; Zhou P; Li XW; Wu Z; Zhang KY; Xing JC
Int J Clin Exp Pathol; 2015; 8(6):6901-9. PubMed ID: 26261577
[TBL] [Abstract][Full Text] [Related]
12. Dissociation of renin and aldosterone during low-dose epinephrine infusion.
Kruse HJ; Kreutz R; Staib S; Overlack A; Stumpe KO; Kolloch RE
Am J Hypertens; 1994 Oct; 7(10 Pt 1):913-8. PubMed ID: 7826555
[TBL] [Abstract][Full Text] [Related]
13. Effects of dibutyryladenosine 3',5'-monophosphate on steroid biosynthesis in humans.
Fukuda N; Honda M; Hatano M
Endocrinol Jpn; 1986 Jun; 33(3):323-32. PubMed ID: 3019651
[TBL] [Abstract][Full Text] [Related]
14. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
[TBL] [Abstract][Full Text] [Related]
15. beta-Endorphin stimulates plasma renin and aldosterone release in normal human subjects.
Rabinowe SL; Taylor T; Dluhy RG; Williams GH
J Clin Endocrinol Metab; 1985 Mar; 60(3):485-9. PubMed ID: 3156142
[TBL] [Abstract][Full Text] [Related]
16. Combination of LC-MS/MS aldosterone and automated direct renin in screening for primary aldosteronism.
Juutilainen A; Savolainen K; Romppanen J; Turpeinen U; Hämäläinen E; Kemppainen J; Moilanen L; Pulkki K
Clin Chim Acta; 2014 Jun; 433():209-15. PubMed ID: 24661979
[TBL] [Abstract][Full Text] [Related]
17. Alpha-h-ANP injection in normals, low renin hypertension and primary aldosteronism.
Mantero F; Rocco S; Pertile F; Carpené G; Fallo F; Menegus A
J Steroid Biochem; 1987; 27(4-6):935-40. PubMed ID: 2961943
[TBL] [Abstract][Full Text] [Related]
18. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.
Fardella CE; Mosso L; Gómez-Sánchez C; Cortés P; Soto J; Gómez L; Pinto M; Huete A; Oestreicher E; Foradori A; Montero J
J Clin Endocrinol Metab; 2000 May; 85(5):1863-7. PubMed ID: 10843166
[TBL] [Abstract][Full Text] [Related]
19. [Aldosterone/renin ratio in the diagnosis of primary aldosteronism].
Ríos MC; Izquierdo A; Sotelo M; Honnorat E; Rodríguez Cuimbra S; Catay E; Popescu BM
Medicina (B Aires); 2011; 71(6):525-30. PubMed ID: 22167725
[TBL] [Abstract][Full Text] [Related]
20. SFE/SFHTA/AFCE Consensus on Primary Aldosteronism, part 2: First diagnostic steps.
Douillard C; Houillier P; Nussberger J; Girerd X
Ann Endocrinol (Paris); 2016 Jul; 77(3):192-201. PubMed ID: 27177498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
